Neuroanesthesia
General Information
1. Provide general information on neuroanesthesia. |
|
|
a. Name the most potent cerebral vaso dilator. | CO2 | G7 p.1:85mm |
b. Effect of hyperventilation on |
| G7 p.1:85mm |
i. PaCO2 | reduces |
|
ii. CBV | decreases |
|
iii. CBF | decreases |
|
iv. Goal is end tidal CO2 of (ETCO2) _____ | 25 to 30 mm Hg |
|
v. Correlates with a PCO2 of _____ | 30 to 35 mm Hg |
|
c. For every_____ degree change in temperature | 1 | G7 p.1:110mm |
d. there is a change in cerebral metabolic rate of oxygen by_____%. | 7% |
|
e. The effect that hyperglycemia has on ischemic deficits is to make them _____. | worse | G7 p.1:115mm |
f. Elevating the patient’s head will have the following effect on: |
| G7 p.1:127mm |
i. arterial blood flow | decreases |
|
ii. ICP | reduces |
|
iii. venous blood outflow | improves |
|
Drugs Used in Neuroanesthesia
2. Inhalation anesthesia agents have the following effects: |
| G7 p.1:177mm |
a. cerebral vessels_____ | dilate |
|
b. auto-regulation is_____ | disturbed |
|
c. cerebral blood volume is_____ | increased |
|
d. CSF volume is_____ | increased |
|
e. Reactivity of vessels to CO2 is_____ | increased |
|
3. What anesthetic drug may come out of solution and aggravate pneumocephalus? | nitrous oxide | G7 p.2:45mm |
4. To reduce the risk of tension pneumocephalus you would |
| G7 p.2:52mm |
a. fill any space with_____ | fluid |
|
b. and turn off_____ | agent |
|
c. _____ minutes before closing the dura. | 10 |
|
5. Complete the following regarding barbiturates: |
| G7 p.2:147mm |
a. Most are anticonvulsants but there is an exception that actually lowers the seizure threshold called B_____. | Brevital |
|
b. They cause peripheral vaso_____ | dilatation |
|
c. which may cause_____ | hypotension |
|
d. and_____ the CPP. | reduce |
|
6. True or False. Morphine and Demoral |
| G7 p.3:42mm |
a. release histamine | true |
|
b. produce hypotension | true |
|
c. cause vasodilation | true |
|
d. increase ICP | true |
|
e. compromise CPP | true |
|
f. Demoral can cause seizures. | true |
|
7. Characterize synthetic narcotics. |
| G7 p.3:72mm |
a. Have the advantage that they don’t cause h_____ r_____. | histamine release |
|
b. An example is f_____. | fentanyl | G7 p.3:85mm |
8. Benzodiazepines are_____agonists. | GABA | G7 p.3:115mm |
9. Characterize pancuronium (Pavulon). |
| G7 p.4:40mm |
a. Potentially,_____ minutes are necessary for full reversal of pancuronium (Pavulon). | 20 |
|
b. True or false. Due to its long action it is indicated for intubation. | false |
|
10. Answer the following questions concerning anesthesia requirements for evoked potential monitoring: |
| G7 p.4:177mm |
a. What technique is preferred? | total IV anesthesia |
|
b. Second best is_____. | nitrous/narcotic |
|
c. Are muscle relaxants permitted? | yes |
|
d. How should fentanyl be infused? | continuously as opposed to intermittent injections |
|
11. The antiepileptic drugs that do not effect SSEP are |
| G7 p.5:25mm |
a. c_____ | carbamazepine |
|
b. p_____ | phenytoin |
|
c. p_____ | phenobarbital |
|

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

